NMPA Approval

Alirocumab injection

Approval Number

国药准字SJ20255002

Registration Date

April 16, 2025

Previous Approval Numbers

国药准字SJ20190042

Drug Information

Generic Name

阿利西尤单抗注射液

Trade Name

波立达

Dosage Form

注射剂

Strength

1.0mL:75mg预充式注射器

Drug Type

生物制品

Registration Date

April 16, 2025

Expiry Date

May 28, 2029

Company Address

82 avenue Raspail, 94250 Gentilly, France

Company Address

1051 Boulevard Industriel, 76580 Le Trait, France

Empowering clinical research with data-driven insights and AI-powered tools.

阿利西尤单抗注射液 - NMPA 批准文号 | MedPath